(Sr.) Director of Value, Access and Policy, Europe

Primary Responsibilities:

• Primary focus will be to support the mid-size and small European countries.
• Ensure that Pricing and Access launch strategies in the focus countries are of high quality and are fit-for- purpose
• Based on insights, develop pricing & access strategies incorporating additional evidence needs, value proposition beyond the drug, managed entry schemes and other agreements to ensure mutual value, and pricing strategy.
• Ensure high quality and timely delivery of the P&R dossiers.
• In collaboration with local and European teams, identify evidence requirements for successful access in Europe and support the creation of program-specific Evidence Plans.
• Ensure coordinated negotiation strategy with clearly defined approach.
• Develop appropriate broad stakeholder relationships to support access engagement and education – including appropriate consultation of patients regarding their needs and the impact of the disease in their local context.
• Establish and maintain personal relationships with select payers, advisors, key opinion leaders and other stakeholders.
• Prepare and manage annual strategic plans and budgets for the function with accurate forecasting and prudent decision making.
• Monitor trends and anticipate key developments in Europe with respect to Health Technology Assessment and Government/Payer reimbursement initiatives.

Education/Experience/Skills:

Bachelor’s degree required, MBA or PhD in science and/or economics preferred. Minimum of 10 years progressively increasing responsibilities in Market Access within a pharmaceutical/biotech organization with significant scientific exposure within rare disease, ideally in the CNS realm, and in the context of early patient access programs. A combination of relevant education and applicable experience may be considered.

Key Skills:

• Recent experience in early patient access programs and launch of orphan drugs ideally with direct or adjacent experience within the CNS space.
• Hands-on experience in pricing negotiations in one or more European markets
• Experience and proven success in cross-functional teamwork
• Fluency in English (written and oral) mandatory, additional European languages are considered an advantage
• Ability to collaborate cross-functionally with commercial, medical, clinical and regulatory colleagues to foster a culture of collaboration and innovation.
• Strong digital literacy and Microsoft proficiency (Excel and PowerPoint in particular)
• Excellent written and oral communication skills, including strong formal presentation skills.
• Ability to travel, both within Europe and internationally.

#LI-HYBRID